These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1027634)

  • 21. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic and endocrine changes associated with hypotensive action of amosulalol in essential hypertension.
    Ando K; Noda H; Ogata E; Fujita T
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):7-10. PubMed ID: 1383633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cadralazine on systemic blood pressure, renal function and plasma renin activity in anesthetized dogs.
    Yukimura T; Miura K; Tanaka M; Higashio T; Sakaguchi S; Kuroda K; Yamamoto K
    Arzneimittelforschung; 1988 Jan; 38(1):25-8. PubMed ID: 3284531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the acute hemodynamic and coronary vasodilating effects between nicorandil and glyceryl trinitrate.
    Chibana T; Nagamine F; Sunagawa R; Oshiro K; Nakada Y; Shimabukuro M; Shinzato T; Murakami K; Mimura G; Sakanashi M
    Arzneimittelforschung; 1991 Jun; 41(6):591-4. PubMed ID: 1834065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onthe pharmacology of 3-hydrazino-6-(N,N-bis(2-hydroxyethyl)amino)-pyridazine-dihydrochloride (L 6150).
    Baldoli E; Sardi A; Dezulian V; Capellini M; Bianchi G
    Arzneimittelforschung; 1973 Nov; 23(11):1591-5. PubMed ID: 4801666
    [No Abstract]   [Full Text] [Related]  

  • 26. Regional coronary hemodynamics during isoflurane-nitrous oxide anesthesia in patients with ischemic heart disease.
    Reiz S; Ostman M
    Anesth Analg; 1985 Jun; 64(6):570-6. PubMed ID: 4003774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of glucagon on systemic circulation, coronary blood flow and myocardial oxygen consumption in the anesthetized dog (author's transl)].
    Tarnow J; Gethmann JW; Patschke D; Weymar A; Eberlein HJ
    Arzneimittelforschung; 1975; 25(12):1906-10. PubMed ID: 1243661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction.
    De Luca L; Proietti P; Celotto A; Bucciarelli-Ducci C; Benedetti G; Di Roma A; Sardella G; Genuini I; Fedele F
    Am Heart J; 2005 Sep; 150(3):563-8. PubMed ID: 16169341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemodynamic effects of selective alpha 1-blockade (trimazosin) in essential hypertension.
    Nelson GI; Hussain M; Forsyth D; Wilson J; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1984; 6(1):176-81. PubMed ID: 6199601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of three metabolites of 3-hydrazino-6-[bis-(2-hydroxyethyl)amino]pyridazine. A new rearrangement of 3-[1-methylethyliden)hydrazino] derivative.
    Bellasio E; Campi A
    Farmaco Sci; 1978 Aug; 33(8):565-72. PubMed ID: 744255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zatebradine, a specific bradycardic agent, alters the hemodynamic and left ventricular mechanical actions of levosimendan, a new myofilament calcium sensitizer, in conscious dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    J Pharmacol Exp Ther; 1995 Oct; 275(1):127-35. PubMed ID: 7562540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cardiovascular effects of dimethophrine in the dog].
    Monguzzi G; Romano A; Scrollini F
    G Ital Cardiol; 1973; 3(1):102-11. PubMed ID: 4695015
    [No Abstract]   [Full Text] [Related]  

  • 33. The haemodynamic and metabolic effects of tolmesoxide with special reference to impaired myocardial function.
    Mackenzie JE; Marshall RJ; Parratt JR
    Br J Pharmacol; 1986 Oct; 89(2):313-9. PubMed ID: 3779213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological studies of a newly synthetized 1,4-dihydropyridine derivative, 2,6-dimethyl-3,5-dimethoxycarbonyl-4- (o-difluoromethoxyphenyl)-1,4-dihydropyridine (PP-1466).
    Toribatake T; Fujii K; Kobayashi M; Okumura M; Aikawa K
    Arzneimittelforschung; 1985; 35(4):680-6. PubMed ID: 4015734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemodynamic effects of propranolol in hypertension: a review.
    Tarazi RC; Dustan HP; Bravo EL
    Postgrad Med J; 1976; 52 Suppl 4():92-100. PubMed ID: 787955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Search for pyridazine derivatives with hypotensive action].
    Bałoniak S; Drozdzyńska E; Linkowska E; Mroczkiewicz MF; Oledzka K; Zyczyńska-Bałoniak I
    Acta Pol Pharm; 1979; 36(3):295-300. PubMed ID: 517146
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cardiocirculatory effects of a new sympathomimetic, amezinium methyl sulfate. Results of human pharmacological studies].
    Schaps D; Seitz W; Hetzer R; Tholen A; Goroll D
    Anaesthesist; 1985 Feb; 34(2):79-84. PubMed ID: 3985303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of captopril on the coronary circulation and myocardial metabolism of patients with coronary artery disease.
    Mettauer B; Rouleau JL; Daly P
    Postgrad Med J; 1986; 62 Suppl 1():54-8. PubMed ID: 3534864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.
    Petta JM; Zaccheo VJ
    J Pharmacol Exp Ther; 1971 Feb; 176(2):328-38. PubMed ID: 4998691
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular effects of levosimendan in the early stages of endotoxemia.
    Cunha-Goncalves D; Perez-de-Sa V; Dahm P; Grins E; Thörne J; Blomquist S
    Shock; 2007 Jul; 28(1):71-7. PubMed ID: 17510599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.